AVITA Medical Q4 2023 GAAP EPS $(0.28) Beats $(0.38) Estimate, Sales $14.20M Miss $14.50M Estimate
Author: Benzinga Newsdesk | February 22, 2024 05:02pm
AVITA Medical (NASDAQ:
RCEL) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.38) by 26.32 percent. The company reported quarterly sales of $14.20 million which missed the analyst consensus estimate of $14.50 million by 2.10 percent. This is a 50.13 percent increase over sales of $9.46 million the same period last year.
Posted In: RCEL